Bio-Techne

Bio-Techne

Yahoo Finance • 2 days ago

3 Reasons to Sell TECH and 1 Stock to Buy Instead

3 Reasons to Sell TECH and 1 Stock to Buy Instead Bio-Techne has had an impressive run over the past six months as its shares have beaten the S&P 500 by 21.5%. The stock now trades at $72.56, marking a 39.5% gain. This was partly due to i... Full story

Yahoo Finance • 2 days ago

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany

MINNEAPOLIS, Sept. 23, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt... Full story

Yahoo Finance • last month

1 Profitable Stock to Own for Decades and 2 We Turn Down

1 Profitable Stock to Own for Decades and 2 We Turn Down Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will thrive... Full story

Yahoo Finance • 2 months ago

Investors’ Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 In... Full story

Yahoo Finance • 2 months ago

2 S&P 500 Stocks to Keep an Eye On and 1 We Turn Down

2 S&P 500 Stocks to Keep an Eye On and 1 We Turn Down While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or... Full story

Yahoo Finance • 2 months ago

1 Healthcare Stock Worth Your Attention and 2 We Question

1 Healthcare Stock Worth Your Attention and 2 We Question From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong fina... Full story

Yahoo Finance • 2 months ago

Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?

Investors choosing between Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) and Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RSPH) must weigh the lower cost and top-heavy concentration of FHLC against the broader equal-weighted... Full story

Yahoo Finance • 2 months ago

Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026?

Key Points Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to the 25 positions in VanEck Biotech ETF VanEck Biotech ETF has a slightly lower expense ratio of 0.35% while Invesco S&P 500 Equ... Full story

Yahoo Finance • 3 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LCI Industries (NYSE – LCII), Iridium Communications Inc. (Nasdaq – IRDM), Bio-Techne Corporation (Nasdaq – TECH), Arcosa, Inc. (NYSE – ACA)

BALA CYNWYD, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 3 months ago

Halper Sadeh LLC is Investigating Whether IRDM, TECH, SUNE, ACA are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 3 months ago

Merck KGaA to acquire Bio-Techne in $11.3 billion deal

Merck KGaA agreed to acquire Minneapolis-based Bio-Techne Corporation for $73 per share in cash, valuing the life-sciences tools supplier at an enterprise value of approximately $11.3 billion. The offer represents a 36% premium to Bio-Tec... Full story

Yahoo Finance • 3 months ago

Bio-Techne (TECH) Soars 20% on Merck $11.3B Merger

Bio-Techne Corp. (NASDAQ:TECH) is one of the 9 Stocks Winning by Double Digits. Bio-Techne rallied for a third straight day on Thursday, surging 20.08 percent to close at $70.70 apiece, as investors gobbled up shares following news that i... Full story

Yahoo Finance • 3 months ago

Stocks Settle Mixed on Apple Weakness and Chipmaker Strength

The S&P 500 Index ($SPX) (SPY) on Thursday closed down -0.01%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.75%.  September E-mini S&P futures (ESU26) rose +0.01%, and... Full story

Yahoo Finance • 3 months ago

Stocks making the biggest moves midday: BlackBerry, Kymera Therapeutics, Apple, Wendy's & more

Check out the companies making the biggest moves midday: Kymera Therapeutics — The biotech stock surged 17% after Kymera enrolled in a Phase 2b Broaden2 trial for its KT-621 drug, which aims to treat atopic dermatitis. BlackBerry — Shares... Full story

Yahoo Finance • 3 months ago

Stocks Climb on Micron Earnings and Economic Optimism

The S&P 500 Index ($SPX) (SPY) today is up +0.31%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.21%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.55%.  September E-mini S&P futures (ESU26) are up +0.26%, and September E-mini... Full story

Yahoo Finance • 3 months ago

Stocks Erase Early Gain as Megacap Tech Stocks Retreat

The S&P 500 Index ($SPX) (SPY) today is down -0.18%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.49%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.20%.  September E-mini S&P futures (ESU26) are down -0.30%, and September E... Full story

Yahoo Finance • 3 months ago

Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion

Merck KGaA has agreed to acquire life sciences company Bio-Techne Corporation for $11.3bn, representing one of the largest financial outlays by a drugmaker so far this year. As per the deal, Merck will pay $73 for each of Bio-Techne's US-... Full story

Yahoo Finance • 3 months ago

Bio-Techne to Be Acquired by Germany's Merck in $11.3 Billion Deal

Bio-Techne (TECH) said Thursday it has agreed to be acquired by Merck KGaA in an all-cash deal with PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 3 months ago

Germany’s Merck Is Buying Bio-Techne for $11.3 Billion

Shares of Bio-Techne surged before the opening bell on Thursday after Germany’s Merck KGaA announced it has agreed to purchase the company for $11.3 billion. Bio-Techne stock jumped 21% to $70.95 in premarket trading on Thursday. Mer... Full story

Yahoo Finance • 3 months ago

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin post-closing, and EPS pre accreti... Full story